Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Molecules (Basel, Switzerland)|December 11, 2022
Formation of miRNA Nanoprobes-Conjugation Approaches Leading to the FunctionalizationIveta Vilímová, Katel Hervé-Aubert, Igor Chourpa
International Journal of Pharmaceutics|September 27, 2021
Active targeting strategy in nanomedicines using anti-EGFR ligands - A promising approach for cancer therapy and diagnosisPhuoc Vinh Nguyen, Katel Hervé-Aubert, Igor Chourpa, et al.
RSC Advances|April 15, 2022
Two-step formulation of magnetic nanoprobes for microRNA captureIveta Vilímová, Igor Chourpa, Stéphanie David, et al.
International Journal of Pharmaceutics|June 13, 2021
Nanomedicines functionalized with anti-EGFR ligands for active targeting in cancer therapy: Biological strategy, design and quality controlPhuoc Vinh Nguyen, Emilie Allard-Vannier, Igor Chourpa, et al.
Journal of Liposome Research|March 9, 2024
Design, optimization, characterization, and in vitro evaluation of metformin-loaded liposomes for triple negative breast cancer treatmentDaiva Vozgirdaite, Katel Hervé-Aubert, Rustem Uzbekov, et al.
Nanotechnology|September 10, 2013
Colloidal stability and thermo-responsive properties of iron oxide nanoparticles coated with polymers: advantages of Pluronic® F68-PEG mixtureManuela Chiper, Katel Hervé Aubert, Amélie Augé, et al.
Pharmaceutics|June 24, 2022
Peptides to Overcome the Limitations of Current Anticancer and Antimicrobial NanotherapiesValentina Del Genio, Rosa Bellavita, Annarita Falanga, et al.
Journal of Colloid and Interface Science|April 8, 2017
Synthesis and in vitro evaluation of fluorescent and magnetic nanoparticles functionalized with a cell penetrating peptide for cancer theranosisEmiliana Perillo, Katel Hervé-Aubert, Emilie Allard-Vannier, et al.
International Journal of Pharmaceutics|June 4, 2013
Use of experimental design methodology for the development of new magnetic siRNA nanovectors (MSN)Stephanie David, Hervé Marchais, Katel Hervé-Aubert, et al.
International Journal of Pharmaceutics|October 25, 2022
WITHDRAWN: In vitro synergistic activity of cisplatin and EGFR-targeted nanomedicine of anti-Bcl-xL siRNA in a non-small lung cancer cell line modelPhuoc Vinh Nguyen, Katel Hervé-Aubert, Laurie Lajoie, et al.
Pageof 3